Back to Newsroom

Curis Reports Fourth Quarter and Year-End 2017 Financial Results

LEXINGTON, Mass., March 8, 2018 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today reported its financial results for the fourth quarter and year ended December 31, 2017.